Javascript must be enabled to continue!
Nonfluoroscopic catheter ablation of tachyarrhythmias in patients with antiarrhythmic devices
View through CrossRef
Aim. To assess safety and effectiveness of zero fluoro catheter ablation (CA) of tachyarrhythmias in patients with antiarrhythmic device.Methods. One hundred ninety-seven patients with implanted antiarrhythmic device and indication for catheter ablation of tachyarrhythmias were included in retrospective study. In control group of patients n=63 (mean age 65.5±11.9 years) all procedures were performed under fluoroscopic guidance. In a study group, n=134 (mean age 66.1±15.6 years) all procedures were performed without the use of fluoroscopy. To reconstruct 3D anatomy we used navigation systems: magnet and impedance. In some cases we used intracardiac ultrasound. In the first group there were 65% of patients with pacemakers, 4.8% patients with implantable cardioverters-defibrillators and 30.2% of patients had cardiac resynchronization systems. In second 70.1%, 12.7% and 17.2% respectively. In control group CA was performed within 24 hours after device implantation in 13 patients (20.6%), in study group - 23 (17.2%). In the rest cohort of patients mean period between device implantation and CA was 29.26±28 months - in control group, 38.8±39 months. Antiarrhythmic device programming was performed before and right after CA.Results. Interventional catheter procedure was performed in 98.4% of patients in control group and in 98.5% of patients in study group. Radiation exposure in control group was 0.24 mZv, in study group 0 mZv. There were no conversions from zero fluoroscopy procedure to X -ray controlled due to different reasons. In control (fluoroscopy controlled) group 8 hours after CA ventricle lead dislodgement was diagnosed. Antiarrhythmic device in this patient was implanted 6 days before CA. There were no lead dislodgements or cardiac pacing disorders in study group.Conclusion. Zero fluoroscopy CA of tachyarrhythmias in patients with antiarrhythmc device is as safe and effective as standard fluoroscopy controlled procedure.
Institute of Cardio Technics - INCART
Title: Nonfluoroscopic catheter ablation of tachyarrhythmias in patients with antiarrhythmic devices
Description:
Aim.
To assess safety and effectiveness of zero fluoro catheter ablation (CA) of tachyarrhythmias in patients with antiarrhythmic device.
Methods.
One hundred ninety-seven patients with implanted antiarrhythmic device and indication for catheter ablation of tachyarrhythmias were included in retrospective study.
In control group of patients n=63 (mean age 65.
5±11.
9 years) all procedures were performed under fluoroscopic guidance.
In a study group, n=134 (mean age 66.
1±15.
6 years) all procedures were performed without the use of fluoroscopy.
To reconstruct 3D anatomy we used navigation systems: magnet and impedance.
In some cases we used intracardiac ultrasound.
In the first group there were 65% of patients with pacemakers, 4.
8% patients with implantable cardioverters-defibrillators and 30.
2% of patients had cardiac resynchronization systems.
In second 70.
1%, 12.
7% and 17.
2% respectively.
In control group CA was performed within 24 hours after device implantation in 13 patients (20.
6%), in study group - 23 (17.
2%).
In the rest cohort of patients mean period between device implantation and CA was 29.
26±28 months - in control group, 38.
8±39 months.
Antiarrhythmic device programming was performed before and right after CA.
Results.
Interventional catheter procedure was performed in 98.
4% of patients in control group and in 98.
5% of patients in study group.
Radiation exposure in control group was 0.
24 mZv, in study group 0 mZv.
There were no conversions from zero fluoroscopy procedure to X -ray controlled due to different reasons.
In control (fluoroscopy controlled) group 8 hours after CA ventricle lead dislodgement was diagnosed.
Antiarrhythmic device in this patient was implanted 6 days before CA.
There were no lead dislodgements or cardiac pacing disorders in study group.
Conclusion.
Zero fluoroscopy CA of tachyarrhythmias in patients with antiarrhythmc device is as safe and effective as standard fluoroscopy controlled procedure.
Related Results
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract
Introduction
Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Pacemaker and AV node ablation after multiple AF ablation procedures: a patients perspective - The PANAMA PAPER
Pacemaker and AV node ablation after multiple AF ablation procedures: a patients perspective - The PANAMA PAPER
Abstract
Funding Acknowledgements
Type of funding sources: None.
Objectives
...
The advantage of mini electrode-equipped catheter for the radiofrequency ablation of paroxysmal supraventricular tachycardia
The advantage of mini electrode-equipped catheter for the radiofrequency ablation of paroxysmal supraventricular tachycardia
Introduction: Novel ablation catheters equipped with
mini-electrodes (ME) offer high resolution mapping for target tissue.
This study aimed to evaluate the mapping performance and ...
The evaluation of irrigating ablation catheter in the treatment for severely symptomatic premature ventricular contractions
The evaluation of irrigating ablation catheter in the treatment for severely symptomatic premature ventricular contractions
Introduction
Radiofrequency catheter ablation (RFCA) of symptomatic ventricular premature contractions has been reported to be a safe and effective treatment opti...
Abstract 4138840: Hybrid Convergent Procedure as a ‘Bail Out’ Strategy In Patients with Atrial Fibrillation Resistant To Catheter Ablation
Abstract 4138840: Hybrid Convergent Procedure as a ‘Bail Out’ Strategy In Patients with Atrial Fibrillation Resistant To Catheter Ablation
Introduction:
Atrial fibrillation (AF) is a common and symptomatic arrhythmia which can be resistant to conventional endocardial catheter ablation. The Hybrid Convergen...
Initial Human Feasibility of Infusion Needle Catheter Ablation for Refractory Ventricular Tachycardia
Initial Human Feasibility of Infusion Needle Catheter Ablation for Refractory Ventricular Tachycardia
Background—
Ablation of ventricular tachycardia (VT) is sometimes unsuccessful when ablation lesions are of insufficient depth to reach arrhythmogenic substrate. We rep...
Ablation Performance of C/SiC-ZrC Composites
Ablation Performance of C/SiC-ZrC Composites
Abstract
To reveal the ablation performance of C/SiC-ZrC composites under different ablation methods, C/SiC-ZrC composites were prepared by chemical vapor deposition and pr...
Recent Advances in Catheter Ablation for Atrial Fibrillation and Non-pharmacological Stroke Prevention
Recent Advances in Catheter Ablation for Atrial Fibrillation and Non-pharmacological Stroke Prevention
Atrial Fibrillation is a common arrhythmia affecting 6 million people in the United States and 33 million people worldwide, associated with significant morbidity. Whereas restorati...

